| Knowledge of laboratory diagnosis |
Frequency (n = 131) |
Percentage (100%) |
|||||
| According to CDC, the following specimens can be used in the laboratory detection of SARS-CoV-2 Blood Oropharyngeal/Throat Swab Feaces Vaginal/Urethral Swab Nasopharyngeal/Nasal Swabs CSF |
62 108 10 8 92 11 |
47.3 82.4 7.6 6.1 70.2 8.4 |
|||||
| CDC criteria for specimen rejection for COVID-19 testing Specimens not kept at 2-4 degree Celsius Incomplete specimen labeling or documentation Undiluted specimen Inappropriate specimen type |
63 105 19 99 |
48.1 80.2 14.5 75.6 |
|||||
| Single Double Triple Galvanized Aerated |
21 32 36 30 12 |
16.0 24.4 27.5 22.9 9.2 |
|||||
| One of the hallmarks of COVID-19 Lymphocytosis Lymphopenia Increased LDH Increased Albumin Prolong PT |
81 49 27 26 18 |
61.8 37.4 20.6 19.8 13.7 |
|||||
| Arrange the following Coronavirus detection steps in the right order: Fluorescent signal detection, 2. Reverse transcription of RNA to cDNA, 3. RNA isolation 4. cDNA amplification with real-time PCR, 5. RNA purification 1 5 3 4 2 2 3 4 5 1 5 4 2 1 3 3 5 2 4 1 4 1 5 4 3 2 |
24 14 24 59 0 |
18.3 10.7 18.3 45.0 7.6 |
|||||
|
|
Strongly agree n (%) |
Agree n (%) |
Slightly agree n (%) |
Slightly disagree n (%) |
Disagree n (%) |
Strongly disagree n (%)
|
|
| The collected specimen must be put into a viral transport medium |
78 (59.5) |
48 (36.6) |
2 (1.5) |
1 (0.8) |
2 (1.5) |
0 (0.0) |
|
| Diffuse alveolar damage characterized by presence of cellular fibromyxoid exudates, desquamation of pneumocytes and hyaline membrane formation is diagnostic pulmonary histology in COVID-19 |
38 (29.0) |
61 (46.6) |
20 (15.2) |
8 (6.1) |
4 (3.1) |
0 (0.0) |
|
| Total |
131 |
100 |
|||||